[Antibodies in patients with cervicouterine carcinoma].
Cervical smears and serum samples were obtained from 28 ABO compatible patients with carcinoma of the cervix (CaCx) in O to IV clinical stages. Serum IgG antibodies against autologous CaCx cells were detected by immunofluorescence reactions in 24/24 patients with carcinoma of the cervix in I to IV clinical stages. These antibodies also reacted against alogeneic CaCx cells 53/54. Negative reactions were obtained n 4/4 cases of carcinoma of the cervix in stage O, and in control group, 10 normal persons and in 33 neoplastic sera from patients with other malignancies. Hence, detection of serum antibodies against CaCx cells could be an additional tool for CaCx detection.
D000017:ABO Blood-Group System; D000328:Adult; D000912:Antibodies, Neoplasm / Q000032:analysis*; D002584:Cervix Uteri / Q000473:pathology; D004848:Epithelium / Q000473:pathology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007106:Immune Sera / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D008875:Middle Aged; D018139:Simplexvirus / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000473:pathology
D000017:ABO Blood-Group System; D000912:Antibodies, Neoplasm; D007106:Immune Sera; D007074:Immunoglobulin G
Anticuerpos en pacientes con carcinoma cercicouterino